Product Information
FYCOMPA 0.5 MG/ML ORAL SUSP is a brand product labeled by Catalyst Pharmaceuticals, Inc., priced at $4.4587 per ML under NDC 69616029038. Its NADAC has been published 133 times since Feb 7, 2024.
FDA first approved this application on Apr 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/mL
Manufacturer
Catalyst Pharmaceuticals, Inc.NDC
69616029038
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PERAMPANELApproval Type
New Drug (NDA)
FDA Application
NDA208277FDA Approved
4/29/2016
TE Code
AB
On Market Since
1/2/2024
Pharmacological Classes
Price Statistics
The NADAC for FYCOMPA 0.5 MG/ML ORAL SUSP has been published 133 times since Feb 7, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4587 per ML |
|---|---|
| All-time high | $4.4770 (Jun 12, 2024) |
| All-time low | $4.4587 (Aug 19, 2026) |
| 52-week high | $4.4679 |
| 52-week low | $4.4587 |
| Median price | $4.4664 |
| Average price | $4.4662 |
| Largest weekly change | -0.3% (Jun 19, 2024) |
| Weeks tracked | 133 |
| Tracking since | Feb 7, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FYCOMPA 0.5 MG/ML ORAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for FYCOMPA 0.5 MG/ML ORAL SUSP, manufactured by Catalyst Pharmaceuticals, Inc., is $4.4587 per ML (NDC 69616029038), effective Aug 19, 2026.
How has the price of FYCOMPA 0.5 MG/ML ORAL SUSP changed over time?
Over the history we have for it, the NADAC for FYCOMPA 0.5 MG/ML ORAL SUSP has held within roughly two percent of its current level. It has been tracked across 133 weekly CMS publications since Feb 7, 2024.
What are the highest and lowest recorded NADAC prices for FYCOMPA 0.5 MG/ML ORAL SUSP?
Since Feb 7, 2024, the NADAC for FYCOMPA 0.5 MG/ML ORAL SUSP has ranged from a low of $4.4587 (Aug 19, 2026) to a high of $4.4770 (Jun 12, 2024), with a median of $4.4664 per ML.
Are there cheaper alternatives to FYCOMPA 0.5 MG/ML ORAL SUSP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FYCOMPA 0.5 MG/ML ORAL SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures FYCOMPA 0.5 MG/ML ORAL SUSP?
FYCOMPA 0.5 MG/ML ORAL SUSP (NDC 69616029038) is labeled by Catalyst Pharmaceuticals, Inc., and CMS classifies it as a brand product.